(Q45189238)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

title

Targeting of sodium-glucose cotransporters with phlorizin inhibits polycystic kidney disease progression in Han:SPRD rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

polycystic kidney disease

2 March 2020

main subject

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

Daniel Rodriguez Gutierrez

2 March 2020

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

author name string

Xueqi Wang

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Suhua Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Yang Liu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Daniela Spichtig

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Sarika Kapoor

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Hermann Koepsell

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Nilufar Mohebbi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Andreas L Serra

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Olivier Devuyst

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Changlin Mei

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

Rudolf P Wüthrich

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

language of work or name

English

0 references

publication date

29 May 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

volume

84

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

2 March 2020

page(s)

962-968

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/ki.2013.199

2 March 2020

exact match

0 references

cites work

Autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Fluid transport and cystogenesis in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Polycystic kidney disease: a 2011 update

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Mechanism-based therapeutics for autosomal dominant polycystic kidney disease: recent progress and future prospects.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

https://api.crossref.org/works/10.1038%2FKI.2013.199

1 reference

7 January 2021

Renal glucose transporters: novel targets for hyperglycemia management

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Sodium-glucose transport: role in diabetes mellitus and potential clinical implications.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Rat models of autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Dietary soy protein effects on disease and IGF-I in male and female Han:SPRD-cy rats.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Renal activation of extracellular signal-regulated kinase in rats with autosomal-dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Prospects for mTOR inhibitor use in patients with polycystic kidney disease and hamartomatous diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Everolimus retards cyst growth and preserves kidney function in a rodent model for polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Tolvaptan in autosomal dominant polycystic kidney disease: three years' experience

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Tolvaptan inhibits ERK-dependent cell proliferation, Cl⁻ secretion, and in vitro cyst growth of human ADPKD cells stimulated by vasopressin

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Autosomal dominant polycystic kidney disease is associated with central and nephrogenic defects in osmoregulation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Increased water intake decreases progression of polycystic kidney disease in the PCK rat

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

SGLT2 mediates glucose reabsorption in the early proximal tubule.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Familial renal glucosuria and SGLT2: from a mendelian trait to a therapeutic target.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Effect of dapagliflozin in patients with type 2 diabetes who have inadequate glycaemic control with metformin: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FKI.2013.199

7 January 2021

Identifiers

DOI

10.1038/KI.2013.199

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

2 March 2020

1036649031

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23715121%20AND%20SRC:MED&resulttype=core&format=json